Connect with Inizio at Fierce Pharma Week (booth 1413) to discuss innovation and strategy in the health and life sciences space.
Our experts are set to deliver a series of sessions including:
Lori Klein (Partner, Medical Affairs Practice Lead, Inizio Advisory), with guest speakers, Nikheel Kolatkar (VP, US Medical, Genentech) & Loucif Ouyahia (Global Head of Digital Healthcare, Jazz Pharma)
Precision medical affairs in action: How AI and advanced analytics are reshaping strategy, engagement, and impact
September 10 | 09:45 – 10:15 ET
- Redefining medical affairs with AI: Explore how the function is evolving from insight collection to driving precision strategy, tailored engagement, and measurable outcomes.
- Real-World Impact through data: Learn how AI and analytics are powering strategic planning, stakeholder-specific engagement, and care gap closure.
- From challenges to future frontiers: Hear how biopharma leaders are addressing integration and compliance hurdles while preparing for predictive and generative AI innovations.
Kelly Malloy (SVP, Customer Engagement, Artificial Intelligence & Augmented Intelligence, Inizio Medical)
Real practice, real impact: The business case for next-gen field medical enablement
September 10 | 12:00 – 12:30 ET
- Why traditional training isn’t enough: Highlight the challenges of outdated training methods and their impact on field medical performance, from slow onboarding to inconsistent messaging.
- How technology is changing the game: Explore how AI and new tools can simulate real HCP conversations, personalise learning, and quickly adapt to new data or events.
- Proving the value: Share real examples of how modern training leads to faster ramp-up, stronger HCP engagement, and better results for the business.
Will Reese (Chief Innovation Officer, Inizio Evoke), Theresa Dolge (EVP, Chief Media Officer, Inizio Evoke) & Moderator, Kelly Cusumano (EVP, Growth and Client Innovation, Inizio Evoke)
From Earned to Engineered: A Fireside Chat on How Communications Can Shape AI Brand Authority
September 10 | 14:15 – 14:45 ET
- LLMs Are Rewriting Pharma’s Reputation Engine. As LLMs become health’s dominant source of information, earned media now defines how pharma brands appear and are understood, not just by people, but by machines influencing patients, HCPs, and policymakers.
- From Media Relations to Model Influence. Communications teams must now operate with the same precision as digital teams, ensuring that accurate, high-trust, and relevant content is primed for AI discoverability.
- Trust Isn’t Enough, Visibility Is Vital. If your brand isn’t contributing to the data models rely on, it risks invisibility in key moments of decision-making or dialogue.
- Comms as a Strategic AI Navigator. It’s time for comms to lead with innovation, guiding how brands show up in machine-shaped public square.
Lori Klein (Partner, Medical Affairs Practice Lead, Inizio Advisory) & Jo Ann Saitta (Partner, Global Data Strategy, Analytics and AI Practice Lead, Inizio Advisory)
Precision launch: Integrating data and AI to power commercial & medical strategy
September 10 | 15:45 – 16:15 ET
- Unified data for strategic alignment: How Commercial and Medical Affairs teams collaborate using a centralized, compliant dataset to inform launch strategy with a single source of truth.
- Granular insights for precision engagement: Leveraging tools like Gateway to map patient journeys and provider touchpoints, enabling tailored interactions before and after launch.
- AI-driven orchestration: Using compliant technologies like ClarityNav to identify next best actions and enhance cross-functional coordination through GenAI-powered messaging and customer insights
